Recently, my patients with commercial insurance were paying $15 out of pocket per vial for analogue rapid-acting insulin. A Medicare patient was paying $40 per vial for the same insulin until she entered the “donut hole,” at which point her price went to $102 per vial.
Author: Richard Dolinar
TweetVaccination has been found to be one of the most cost-effective health-care choices. Historically, if a vaccination was approved by the Food and Drug Administration (FDA), the Centers for Disease[…]